Top 200 OTC/HBC brands in 2004
FDA Approves Generic OTC Naloxone Nasal Spray
Amneal Pharmaceuticals said its generic naloxone hydrochloride nasal spray is now available in the US following FDA approval.
Episode 8: Stay in Sync with Innovations in Medication Decision Support
Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.
FDA Issues CRL for Epidermolysis Bullosa Gene Therapy
Abeona Therapeutics’ pz-cel is an investigational autologous, COL7A1 gene-corrected epidermal sheet therapy for the treatment of recessive dystrophic epidermolysis bullosa.
FDA Roundup: Biosimilars, Boxed Warning Added for CAR T-Cell Therapies
Check out important updates from the FDA for the week of April 15.
Stelara Biosimilar Ustekinumab-aekn Recieves FDA Approval
This approval is the second biosimilar approval for manufacturer Alvotech.
FDA Accepts GSK's BLA for 5-in-1 Meningococcal Vaccine
The company’s investigational ABCWY vaccine candidate will be reviewed by the FDA by February 14, 2025.
